Nuclear Imaging Study of the Pharmacodynamic Effects of Debio 1143, an Antagonist of Multiple Inhibitor of Apoptosis Proteins (IAPs), in a Triple-Negative Breast Cancer Model

Pierre-Simon Bellaye¹, Alexandra Oudot¹, Jean-Marc Vrigneaud¹, Olivier Raguin², Francis Bichat², Anne Vaslin³, Hélène Maby-El Hajjami³, Claudio Zanna³, Grégoire Vuagniaux³, Pierre Fumoleau¹, Franck Denat⁴, François Brunotte¹ and Bertrand Collin ^{1 , 4}

Contrast Media Mol Imaging. 2018; 2018: 8494031.

1. Centre Georges-François Leclerc, Dijon, France
2. Oncodesign, Dijon, France
3. Debiopharm International SA, Lausanne, Switzerland
4. ICMUB, Dijon, France